Publications by authors named "Poli Daniela"

Claim this Profile
O
Outcomes of non-valvular atrial fibrillation elderly patients maintained on VKAs' treatment compared to patients switched to DOACs: results from the START-AF registry.
Chiara Cappugi, Emilia Antonucci, Walter Ageno, Sophie Testa, Martina Berteotti, Daniela Poli

Intern Emerg Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring Direct Oral Anticoagulant Levels in Laboratory Practice: Impact of Different Storage Conditions of Blood Samples.
Andrea Sorrentino, Angela Rogolino, Francesca Cesari, Alessia Bertelli, Giulia Ciarrocca Taranta, Daniela Poli

Int J Lab Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Anticoagulant Therapy in Athletes and Sportspeople: Italian Federation of Centers for Diagnosis and Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.
Elena Campello, Chiara Cappugi, Filippo Catalani, Daniela Poli, Paolo Bucciarelli

Thromb Haemost· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose direct oral anticoagulants for secondary prevention in patients at high risk for recurrence due to history of recurrent venous thromboembolic events or severe thrombophilia: a retrospective analysis of the Italian Survey on anTicoagulated pAtients RegisTry 2.
Daniela Poli, Roberto Parisi, Emilia Antonucci, Luca Barcella, Eugenio Bucherini

J Thromb Haemost· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only.
Vittorio Pengo, Luca Sarti, Daniela Poli, Piera Sivera, Doris Barcellona

Semin Thromb Hemost· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry.
Danilo Menichelli, Gianluca Gazzaniga, Daniela Poli, Gualtiero Palareti, Emilia Antonucci

Clin Res Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of direct oral anticoagulants for all-cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry.
Danilo Menichelli, Gianluca Gazzaniga, Emilia Antonucci, Gualtiero Palareti, Daniela Poli

Eur J Clin Invest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty elements, direct oral anticoagulants and mortality risk in atrial fibrillation patients aged ≥ 80 or ≥ 90 years from the nationwide Italian START registry: a propensity score matching analysis.
Danilo Menichelli, Emilia Antonucci, Daniela Poli, Francesco Baratta, Angela Sciacqua

Geroscience· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis.
Danilo Menichelli, Emilia Antonucci, Gianluca Gazzaniga, Daniela Poli, Giuseppe Armentaro

J Am Heart Assoc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry.
Anna Aiello, Luca Sarti, Gilda Sandri, Daniela Poli, Piera Sivera

Int J Lab Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-Label Dosing of Direct Oral Anticoagulants: Prescribing Error or Opportunity in Treating Patients with Atrial Fibrillation?
Daniela Poli

Thromb Haemost· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug Interactions Between DAAs and Anticoagulants or Antiplatelets: A Position Paper of the Italian Anticoagulation Clinics.
Elisabetta Tombolini, Alessandro Squizzato, Gian Marco Podda, Alessio Aghemo, Nicola Ferri, Daniela Poli

Liver Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study.
Gualtiero Palareti, Cristina Legnani, Sophie Testa, Oriana Paoletti, Michela Cini, Daniela Poli

Curr Probl Cardiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events.
Gualtiero Palareti, Sophie Testa, Cristina Legnani, Oriana Paoletti, Michela Cini, Daniela Poli

Int J Cardiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prosthetic valve dysfunction in patients with mechanical heart valves: Results from the Emergency Salam Centre cohort.
Nicoletta Erba, Alberto Tosetto, Suha Abdelwahab Abdallah, Martin Langer, Elena Giovanella, Daniela Poli

Thromb Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study.
Gualtiero Palareti, Sophie Testa, Cristina Legnani, Claudia Dellanoce, Michela Cini, Daniela Poli

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation" [International Journal of Cardiology 407 (2024) 132088].
Andrea Bernardini, Luca Bindini, Emilia Antonucci, Martina Berteotti, Betti Giusti, Daniela Poli

Int J Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence.
Vittorio Pengo, Luca Sarti, Emilia Antonucci, Elisa Bison, Elena Pontara, Daniela Poli

Clin Chem Lab Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.
Silvia Galliazzo, Paolo Bucciarelli, Doris Barcellona, Antonio Ciampa, Elvira Grandone, Daniela Poli

Thromb Haemost· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant Therapy in Pregnant Women with Mechanical Heart Valves: Italian Federation of Centers for Diagnosis and Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.
Elena Campello, Paolo Bucciarelli, Filippo Catalani, Nicoletta Erba, Alessandro Squizzato, Daniela Poli

Thromb Haemost· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation.
Andrea Bernardini, Luca Bindini, Emilia Antonucci, Martina Berteotti, Betti Giusti, Daniela Poli

Int J Cardiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation in Patients with Mechanical Heart Valves: Less Is More?
Daniela Poli, Alessandro Squizzato, Alberto Tosetto

Thromb Haemost· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results.
Gualtiero Palareti, Cristina Legnani, Alberto Tosetto, Daniela Poli, Sophie Testa

Thromb Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry.
Daniela Poli, Emilia Antonucci, Walter Ageno, Martina Berteotti, Anna Falanga

J Clin Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes in Two-Year Follow-Up after Primary Treatment in Patients with a Prior Venous Thromboembolic Event: A Prospective, Observational, Real-Life Study.
Gualtiero Palareti, Emilia Antonucci, Eugenio Bucherini, Antonella Caronna, Antonio Chistolini, Daniela Mastroiacovo, Daniela Poli

J Clin Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis